Failure of lymphocyte microcytotoxicity to distinguish relapsers from non-relapsers in melanoma patients receiving post-surgical adjuvant chemotherapy.
暂无分享，去创建一个
[1] W. Clark,et al. Current concepts of the biology of human cutaneous malignant melanoma. , 1977, Advances in cancer research.
[2] M. Mastrangelo,et al. Sequential in vitro reactivity of lymphocytes from melanoma patients receiving immunotherapy compared with the reactivity of lymphocytes from healthy donors , 1975, International journal of cancer.
[3] F. Kourilsky,et al. Cytotoxicity of lymphocytes from healthy subjects and from melanoma patients against cultured melanoma cells. , 1975, Clinical and experimental immunology.
[4] N. Cascinelli,et al. Lymphocyte toxicity test in clinical melanoma. , 1973, European journal of cancer.
[5] G. Heppner,et al. Cell‐mediated and serum blocking reactivity to tumor antigens in patients with malignant melanoma , 1973, International journal of cancer.
[6] I. Hellstrom,et al. Sequential studies on cell‐mediated tumor immunity and blocking serum activity in ten patients with malignant melanoma , 1973, International journal of cancer.
[7] R. Whitehead,et al. ANTI‐TUMOUR IMMUNOREACTIVITY IN PATIENTS WITH MALIGNANT MELANOMA , 1972, The Medical journal of Australia.
[8] E. Klein,et al. A MICROASSAY FOR CELL-MEDIATED IMMUNITY , 1970, Transplantation.
[9] W. Clark,et al. The histogenesis and biologic behavior of primary human malignant melanomas of the skin. , 1969, Cancer research.